Floatz logo

zx008

Lennox-Gastaut Syndrome

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.UNKNOWNPhase 3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Lennox-Gastaut Syndrome cohort.

Asset / SponsorPhaseRating
gwp42003-p
Jazz Pharmaceuticals
Phase 4BBB
Rufinamide
Eisai Co., Ltd.
Phase 3BB
Benzeneethanamine, N-Ethyl-?-Methyl-4-(Trifluoromethyl)-, Hydrochloride, (±)-
University of Chicago
Phase 3BB
Bexicaserin
Longboard Pharmaceuticals
Phase 2BB
Melatonin
Institution de Lavigny
Phase 4BB

View all 12 →

Same molecule, other indications

zx008 is also rated in:

Dravet syndromeDormant
CC
Indicative · Phase 1
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →